HIV.gov

HIV Research Activities

Supporting Research to Effectively Prevent, Diagnose, and Treat HIV

In the three decades since the first cases of AIDS were reported, Federal investments in basic, biomedical, behavioral, and social science research have led to numerous HIV prevention interventions and life-saving treatment.

HIV Care and Treatment Activities

Improving Health Outcomes, Preventing New Infections

HIV is a virus that can multiply quickly and damage the body’s immune system, making it hard to fight off infections and cancers. While no cure exists for HIV infection, effective treatment is available. Today, there are more than 30 antiretroviral drugs approved by the Food and Drug Administration (FDA) to treat HIV infection.

HIV Prevention Activities

Reducing New HIV Infections

An estimated 37,600 HIV infections are diagnosed each year, according to the most recent CDC data. The Federal approach to reducing new HIV infections is based on the best available scientific evidence and modeling studies have informed decisions about the allocation of resources with regard to the strategies employed, geography, and the populations at greatest risk.

HIV Testing Activities

Supporting Widespread Testing and Timely Linkage to Care

Nearly one in seven people living with HIV in the U.S. are unaware of their infection. As a result, they are not accessing the care and treatment they need to stay healthy and reduce the likelihood of transmitting the virus to their partners. The National HIV/AIDS Strategy prioritizes widespread HIV testing to reduce undiagnosed HIV infection in order to improve the health of people living with HIV and reduce new HIV infections.

Activities Combating HIV Stigma and Discrimination

Ending Stigma and Discrimination Against People Living with HIV

In addition to the serious health issues they face, people living with HIV may often experience stigma and discrimination because of their HIV status. Stigma is an attitude of disapproval and discontent towards an individual or group from other individuals or institutions because of the presence of an attribute perceived as undesirable. Discrimination is often a consequence of stigma, occurring when unfair actions are taken against individuals on the basis of their belonging to a particular stigmatized group.

Background

Origin of the Minority AIDS Initiative and SMAIF

In 1998, the Centers for Disease Control and Prevention (CDC) held a meeting to brief service providers and community leaders on public health surveillance data showing extremely high rates of HIV among African Americans.

Recursos en Español

El VIH es una amenaza de salud grave para las comunidades latinas, quienes se encuentran en gran desventaja respecto de la incidencia de esta enfermedad en los Estados Unidos. Según los CDC, en el 2014 los hispanos representaron aproximadamente el 17% de la población de Estados Unidos, pero constituyeron cerca del 24% de los nuevos casos de infección (10,887). De ellos, el 86 % (9379) fue en hombres y el 14 % (1490) en mujeres.

Pages